Assessing the quality of cancer screening leaflets using the International Patient Decision Aids Standards instrument: A cross-sectional content analysis

2019, Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017, JAMA Oncol., 5, 1749, 10.1001/jamaoncol.2019.2996 Matsuda, 2018, Cancer burden in Japan based on the latest cancer statistics: need for evidence-based cancer control programs, Ann. Cancer Epidemiol., 2, 2, 10.21037/ace.2018.08.01 Japanese Government. Gan Taisaku Kihon Hō. [Cancer Control Act]; 2007. 〈https://www.mhlw.go.jp/shingi/2007/04/dl/s0405–3a.pdf〉 (Accessed 17 Nov 2020). Salzburg Global Seminar, 2011, Salzburg statement on shared decision making, BMJ, 342, d1745, 10.1136/bmj.d1745 Godlee, 2019, Cancer screening: from uptake to informed decision making, BMJ, 367, l5931, 10.1136/bmj.l5931 Woloshin, 2014, The connection between evidence-based medicine and shared decision making, JAMA, 312, 1295, 10.1001/jama.2014.10186 Jørgensen, 2006, Content of invitations for publicly funded screening mammography, BMJ, 332, 538, 10.1136/bmj.332.7540.538 Zapka, 2006, Print information to inform decisions about mammography screening participation in 16 countries with population-based programs, Patient Educ. Couns., 63, 126, 10.1016/j.pec.2005.09.012 Gummersbach, 2010, Are women getting relevant information about mammography screening for an informed consent: a critical appraisal of information brochures used for screening invitation in Germany, Italy, Spain and France, Eur. J. Public Health, 20, 409, 10.1093/eurpub/ckp174 Joseph-Williams, 2013, Toward minimum standards for certifying patient decision aids, Med. Decis. Mak., 34, 699, 10.1177/0272989X13501721 W. Osaka, Y. Yonekura, N. Arimori et al., Jpn. Version IPDASi (Ver. 4. 0) 2017.(Accessed 17 Nov 2020)〈http://www.healthliteracy.jp/pdf/Japanese%20version%20of%20IPDASi%20(v4.0)%20.pdf〉. Ministry of Health, Labour and Welfare of Japan. Imasugu dekiru jushinritsu kōjōsesaku handbook. [A handbook of measures that can be taken right now to improve the uptake] Tokyo: 2016. 〈https://www.mhlw.go.jp/file/06-Seisakujouhou-10900000-Kenkoukyoku/handbook_tanP_180113.pdf〉 (Accessed on 17 Nov 2020.). Director of the Health Bureau, Ministry of Health, Labour and Welfare of Japan. Aratana stage ni haitta gankenshin-no sōgōshienjigyō jisshi yōkō. [Outline of Comprehensive Support Program for Cancer Screening in New Stage] Tokyo: 2018. notification number 0328–20. Elwyn, 2006, Developing a quality criteria framework for patient decision aids: online international Delphi consensus process, BMJ, 333, 10.1136/bmj.38926.629329.AE Fleiss, 1971, Measuring nominal scale agreement among many raters, Psychol. Bull., 76, 378, 10.1037/h0031619 Landis, 1977, The measurement of observer agreement for categorical data, Biometrics, 33, 159, 10.2307/2529310 Beauchamp, 2009 Woloshin, 2012, Cancer screening campaigns — Getting past uninformative persuasion, NEJM, 367, 1677, 10.1056/NEJMp1209407 Gigerenzer, 2017, How new fact boxes are explaining medical risk to millions, BMJ, 357, j2460, 10.1136/bmj.j2460 Schwartz, 2006, Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks, BMJ, 333, 1248, 10.1136/bmj.38985.564317.7C Akl, 2011, Using alternative statistical formats for presenting risks and risk reductions, Cochrane Database Syst. Rev., 10.1002/14651858.CD006776.pub2 Welch, 2000, Are increasing 5-year survival rates evidence of success against cancer?, JAMA, 283, 2975, 10.1001/jama.283.22.2975 Wegwarth, 2012, Do physicians understand cancer screening statistics? A national survey of primary care physicians in the U.S, Ann. Intern. Med., 156, 340, 10.7326/0003-4819-156-5-201203060-00005 Wegwarth, 2011, Deceiving numbers: survival rates and their impact on doctors’ risk communication, Med. Decis. Mak., 31, 386, 10.1177/0272989X10391469 Brenner, 2018, Evaluating shared decision making for lung cancer screening, JAMA Intern. Med., 178, 1311, 10.1001/jamainternmed.2018.3054 Ishikawa, 2012, Cost-effectiveness of a tailored intervention designed to increase breast cancer screening among a non-adherent population: a randomized controlled trial, BMC Public Health, 12, 760, 10.1186/1471-2458-12-760 Hirai, 2016, Tailored message interventions versus typical messages for increasing participation in colorectal cancer screening among a non-adherent population: a randomized controlled trial, BMC Public Health, 16, 431, 10.1186/s12889-016-3069-y